Superiority of rat over murine model for studies on the evolution of cancer genome

References

• Toyokuni S. Oxidative stress as an iceberg in carcinogenesis and cancer biology. Arch Biochem Biophys. 2016;595:46–49.
   PubMed Web of Science ®Google Scholar
• Toyokuni S. Role of iron in carcinogenesis: cancer as a ferrotoxic disease. Cancer Sci. 2009;100:9–16.
   PubMed Web of Science ®Google Scholar
• Toyokuni S. Iron as a target of chemoprevention for longevity in humans. Free Radic Res. 2011;45:906–917.
   PubMed Web of Science ®Google Scholar
• Ohara Y, Chew SH, Shibata T, et al. Phlebotomy as a preventive measure for crocidolite-induced mesothelioma in male rats. Cancer Sci. 2018;109:330–339.
   PubMed Web of Science ®Google Scholar
• Toyokuni S. The origin and future of oxidative stress pathology: from the recognition of carcinogenesis as an iron addiction with ferroptosis-resistance to non-thermal plasma therapy. Pathol Int. 2016;66:245–259.
   PubMed Web of Science ®Google Scholar
• Toyokuni S, Ito F, Yamashita K, et al. Iron and thiol redox signaling in cancer: an exquisite balance to escape ferroptosis. Free Radic Biol Med. 2017;108:610–626.
   PubMed Web of Science ®Google Scholar
• Okada S, Midorikawa O. Induction of rat renal adenocarcinoma by Fe-nitrilotriacetate (Fe-NTA). Jpn Arch Intern Med. 1982;29:485–491.
   Google Scholar
• Ebina Y, Okada S, Hamazaki S, et al. Nephrotoxicity and renal cell carcinoma after use of iron- and aluminum-nitrilotriacetate complexes in rats. J Natl Cancer Inst. 1986;76:107–113.
   PubMed Web of Science ®Google Scholar
• Li JL, Okada S, Hamazaki S, et al. Subacute nephrotoxicity and induction of renal cell carcinoma in mice treated with ferric nitrilotriacetate. Cancer Res. 1987;47:1867–1869.
   PubMed Web of Science ®Google Scholar
• Nishiyama Y, Suwa H, Okamoto K, et al. Low incidence of point mutations in H-, K- and N-ras oncogenes and p53 tumor suppressor gene in renal cell carcinoma and peritoneal mesothelioma of Wistar rats induced by ferric nitrilotriacetate. Jpn J Cancer Res. 1995;86:1150–1158.
   PubMedGoogle Scholar
• Hamazaki S, Okada S, Ebina Y, et al. Acute renal failure and glucosuria induced by ferric nitrilotriacetate in rats. Toxicol Appl Pharmacol. 1985;77:267–274.
   PubMed Web of Science ®Google Scholar
• Hamazaki S, Okada S, Ebina Y, et al. Nephrotoxicity of ferric nitrilotriacetate: an electron-microscopic and metabolic study. Am J Pathol. 1986;123:343–350.
   PubMed Web of Science ®Google Scholar
• Toyokuni S, Uchida K, Okamoto K, et al. Formation of 4-hydroxy-2-nonenal-modified proteins in the renal proximal tubules of rats treated with a renal carcinogen, ferric nitrilotriacetate. Proc Natl Acad Sci USA. 1994;91:2616–2620.
   PubMed Web of Science ®Google Scholar
• Toyokuni S, Mori T, Dizdaroglu M. DNA base modifications in renal chromatin of Wistar rats treated with a renal carcinogen, ferric nitrilotriacetate. Int J Cancer. 1994;57:123–128.
   PubMed Web of Science ®Google Scholar
• Toyokuni S, Mori T, Hiai H, et al. Treatment of Wistar rats with a renal carcinogen, ferric nitrilotriacetate, causes DNA-protein cross-linking between thymine and tyrosine in their renal chromatin. Int J Cancer. 1995;62:309–313.
   PubMed Web of Science ®Google Scholar
• Uchida K, Fukuda A, Kawakishi S, et al. A renal carcinogen ferric nitrilotriacetate mediates a temporary accumulation of aldehyde-modified proteins within cytosolic compartment of rat kidney. Arch Biochem Biophys. 1995;317:405–411.
   PubMed Web of Science ®Google Scholar
• Fukuda A, Osawa T, Oda H, et al. Oxidative stress response in iron-induced renal carcinogenesis: acute nephrotoxicity mediates the enhanced expression of glutathione S-transferase Yp isozyme. Arch Biochem Biophys. 1996;329:39–46.
   PubMed Web of Science ®Google Scholar
• Toyokuni S, Tanaka T, Hattori Y, et al. Quantitative immunohistochemical determination of 8-hydroxy-2. Lab Invest. 1997;76:365–374.
   PubMed Web of Science ®Google Scholar
• Toyokuni S, Luo XP, Tanaka T, et al. Induction of a wide range of C2−12 aldehydes and C7−12 acyloins in the kidney of Wistar rats after treatment with a renal carcinogen, ferric nitrilotriacetate. Free Radic Biol Med. 1997;22:1019–1027.
   PubMed Web of Science ®Google Scholar
• Tanaka T, Kondo S, Iwasa Y, et al. Expression of stress-response and cell proliferation genes in renal cell carcinoma induced by oxidative stress. Am J Pathol. 2000;156:2149–2157.
   PubMed Web of Science ®Google Scholar
• Miller YE, Dwyer-Nield LD, Keith RL, et al. Induction of a high incidence of lung tumors in C57BL/6 mice with multiple ethyl carbamate injections. Cancer Lett. 2003;198:139–144.
   PubMed Web of Science ®Google Scholar
• Li GH, Akatsuka S, Chew SH, et al. Fenton reaction-induced renal carcinogenesis in Mutyh-deficient mice exhibits less chromosomal aberrations than the rat model. Pathol Int. 2017;67:564–574.
   PubMed Web of Science ®Google Scholar
• Stockwell BR, Friedmann Angeli JP, Bayir H, et al. Ferroptosis: a regulated cell death nexus linking metabolism, redox biology, and disease. Cell. 2017;171:273–285.
   PubMed Web of Science ®Google Scholar
• Akatsuka S, Yamashita Y, Ohara H, et al. Fenton reaction induced cancer in wild type rats recapitulates genomic alterations observed in human cancer. PLoS One. 2012;7:e43403.
   PubMed Web of Science ®Google Scholar
• Narimatsu T, Matsuura K, Nakada C, et al. Downregulation of NDUFB6 due to 9p24.1-p13.3 loss is implicated in metastatic clear cell renal cell carcinoma. Cancer Med. 2015;4:112–124.
   PubMed Web of Science ®Google Scholar
• Marsaud A, Dadone B, Ambrosetti D, et al. Dismantling papillary renal cell carcinoma classification: the heterogeneity of genetic profiles suggests several independent diseases. Genes Chromosomes Cancer. 2015;54:369–382.
   PubMed Web of Science ®Google Scholar
• Moch H, Cubilla AL, Humphrey PA, et al. The 2016 WHO classification of tumours of the urinary system and male genital organs-part A: renal, penile, and testicular tumours. Eur Urol. 2016;70:93–105.
   Google Scholar
• Maciak S, Michalak P. Cell size and cancer: a new solution to Peto’s paradox? Evol Appl. 2015;8:2–8.
   PubMed Web of Science ®Google Scholar